Trials / Completed
CompletedNCT03052868
Analysis of Neurocognitive Elements of Attention After Chemotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Data for this study will be obtained from the University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center. Participants will be recruited through Simmons Cancer Center. One hundred female breast cancer patients who have completed adjuvant chemotherapy will be enrolled. In order to reach this number, it is estimated that up to 125 eligible participants will need to be recruited. The study will last approximately two years. Participants will undergo one cognitive testing session, and each subject's total participation time will last no more than two hours.
Detailed description
The study visit will be scheduled for three to six months after completing adjuvant chemotherapy treatment. At the study visit, informed consent will be obtained and neurocognitive attention testing will be performed. The assessments chosen were carefully selected based on breadth, psychometric properties, standardized broad clinical use, good external validity and time efficiency. The testing time for the battery of neuropsychological tests is approximately 45-60 minutes. Participants will also be asked to complete a packet of several questionnaires including several self-rated measures of mood and quality of life, in addition to a brief questionnaire to obtain information about exercise, sleep, and education and employment backgrounds. It is estimated that questionnaire completion will require no more than 30 minutes. Participants will be seen on only one occasion, and may receive, upon request, written feedback about the results of the evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cognitive Assessment | Cognitive testing session |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2017-02-14
- Last updated
- 2017-02-14
Source: ClinicalTrials.gov record NCT03052868. Inclusion in this directory is not an endorsement.